Author： Goldstein Mark R.
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.31, Iss.2, 2008-01, pp. : 181-182
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Statins do not increase the risk of amyotrophic lateral sclerosis
Inpharma, Vol. 1, Iss. 1659, 2008-01 ,pp. :
Access to resources
Recommend
Management of Amyotrophic Lateral Sclerosis
By Corcia Philippe Meininger Vincent
Drugs, Vol. 68, Iss. 8, 2008-01 ,pp. :
By Edwards I. Ralph Star Kristina Kiuru Anne
Drug Safety, Vol. 30, Iss. 6, 2007-01 ,pp. :
Emerging drugs for amyotrophic lateral sclerosis
By Habib Ali Aamer Mitsumoto Hiroshi
Expert Opinion on Emerging Drugs, Vol. 16, Iss. 3, 2011-09 ,pp. :
Therapeutic advances in amyotrophic lateral sclerosis
By Louvel E. Hugon J. Doble A.
Trends in Pharmacological Sciences, Vol. 18, Iss. 6, 1997-06 ,pp. :